Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosisMarc Gurun, Christopher J. Byrne, Damien Leith et al.|PLoS ONE|2024Cited by 29
A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver diseaseDana Ivancovsky‐Wajcman, Jeffrey V. Lazarus, Christopher J. Byrne et al.|Hepatology|2024Cited by 29